Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Diaclone ELISA

Product Image
Product Description
Diaclone ELISA (Enzyme Linked Immuno-Sorbent Assay) are highly sensitive immunoassays designed for the in-vitro quantitative and qualitative determination of cytokines, CD antigens, apoptosis markers and other analytes from human serum, plasma and cell culture supernatant.

The benefits of Diaclone ELISA

•    Highly sensitive ELISA
•    Fast ELISA procedure
•    Accuracy and reliability are guaranteed as all our reagents have been validated according ISO 9001:2008 quality systems
•    Can recognise both Natural and Recombinant antigen specificity
•    Standard Calibration to NIBSC
•    ELISA available in a number of formats from pre-coated kits to matched antibody pairs
•    Removable strip plates and multiple standards allow multiple Assays from each ELISA kit
Product Diaclone ELISA
Company Gen-Probe Inc
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Gen-Probe Inc
10210 Genetic Center Drive San Diego CA 92121 USA

Tel: +1-858-410-8000

Email: marketing@gen-probe.com



Scientific News
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Protein Teams Activate T-Cells
Caltech researchers have discovered T-cell genetic switching is controlled by four proteins acting in a multi-tiered fashion.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!